Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
22
Number of overlapping holdings
32.4%
% of HTEC's 73 holdings also in WDNA
25.0%
% of WDNA's 91 holdings also in HTEC
Overlap by Weight
Sector Drift (HTEC minus WDNA)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in HTEC |
Weight in WDNA |
Overlap | |
|---|---|---|---|---|
 |
NATERA INC | 1.6% | 2.2% | 1.6% |
|
VERTEX PHARMACEUTICALS INC | 1.8% | 1.6% | 1.6% |
|
TWIST BIOSCIENCE CORP. | 1.5% | 4.3% | 1.5% |
|
REGENERON PHARMACEUTICALS | 1.7% | 1.4% | 1.4% |
|
UNITED THERAPEUTICS CORP | 1.4% | 1.5% | 1.4% |
Position Highlights (Non-Overlapping Exposures)
HTEC Overweight Relative to WDNA
|
AXOGEN, INC. | 2.3% |
|
GUARDANT HEALTH, INC. | 2.0% |
|
CHARLES RIVER LABORATORIES | 1.9% |
|
INTUITIVE SURGICAL INC | 1.8% |
 |
LONZA GROUP AG-REG | 1.8% |
 |
DIASORIN SPA | 1.8% |
|
INCYTE CORP | 1.7% |
|
IQVIA HOLDINGS INC | 1.7% |
|
PERKINELMER INC | 1.7% |
|
STAAR SURGICAL CO | 1.7% |
HTEC Underweight Relative to WDNA
|
TWIST BIOSCIENCE CORP. | -2.8% |
 |
NOVOZYMES A/S-B SHARES | -2.7% |
|
BLUEPRINT MEDICINES CORP. | -2.6% |
|
GERON CORP | -2.5% |
|
AGIOS PHARMACEUTICALS INC | -2.4% |
|
FATE THERAPEUTICS INC | -2.2% |
|
VERICEL CORPORATION | -2.1% |
|
ELI LILLY & CO | -2.1% |
|
IOVANCE BIOTHERAPEUTICS INC | -1.7% |
|
SAREPTA THERAPEUTICS INC | -1.7% |